BamSEC and AlphaSense Join Forces
Learn More

PDS Biotechnology Corporation – Indentures

NASDAQ: PDSB    
Share price (7/6/26): $0.85    
Market cap (7/6/26): $47.2 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.2
from 10-Q 15 pages PDS Biotechnology Corporation Warrant to Purchase Common Shares
12/34/56
EX-4.1
from 10-Q 17 pages PDS Biotechnology Corporation Promissory Note
12/34/56
EX-4.3
from 8-K 3 pages Re: Amendment to Existing Warrants Dear Holder: Reference Is Hereby Made to the Offering on or About the Date Hereof (The “Offering”) by PDS Biotechnology Corporation (The “Company”) of Its Common Stock, Par Value $0.00033 Per Share (“Common Stock”) and Warrants to Purchase Its Common Stock (Collectively, the “Securities”)
12/34/56
EX-4.2
from 8-K 18 pages Common Stock Purchase Warrant PDS Biotechnology Corporation
12/34/56
EX-4.1
from 8-K 18 pages Pre-Funded Common Stock Purchase Warrant PDS Biotechnology Corporation
12/34/56
EX-4.3
from S-3 53 pages PDS Biotechnology Corporation Indenture Dated as of [●] [●] Trustee
12/34/56
EX-4.2
from 8-K 18 pages Common Stock Purchase Warrant PDS Biotechnology Corporation
12/34/56
EX-4.1
from 8-K 29 pages Senior Secured Convertible Debenture Due [__], 2028
12/34/56
EX-4.2
from 8-K 18 pages Common Stock Purchase Warrant PDS Biotechnology Corporation
12/34/56
EX-4.1
from 8-K 18 pages Pre-Funded Common Stock Purchase Warrant PDS Biotechnology Corporation
12/34/56
EX-4.3
from S-3 53 pages PDS Biotechnology Corporation Indenture Dated as of [●] [●] Trustee
12/34/56
EX-4.3
from S-3 53 pages PDS Biotechnology Corporation Indenture Dated as of [●] [●] Trustee
12/34/56
EX-4.10
from 10-K 3 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from 8-K 17 pages Registration Rights Agreement
12/34/56
EX-4.3
from S-3 34 pages EDGE Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of , 20 Debt Securities
12/34/56
EX-4.1
from 10-Q 10 pages EDGE Therapeutics, Inc. Common Stock Warrant
12/34/56
EX-4.1
from S-1/A 2 pages Indenture or similar
12/34/56
EX-4.8
from S-1 43 pages Investors’ Rights Agreement by and Among EDGE Therapeutics, Inc., Venrock Healthcare Capital Partners II, L.P., and the Other Investors Named Herein April 6, 2015
12/34/56
EX-4.7
from S-1 9 pages EDGE Therapeutics, Inc. Preferred Stock Warrant
12/34/56
EX-4.6
from S-1 13 pages Warrant Agreement to Purchase Shares of Preferred Stock of EDGE Therapeutics, Inc. Dated as of August 28, 2014
12/34/56